日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemotherapy combined with regorafenib and immune checkpoint inhibitors as a first-line treatment for patients with advanced biliary tract cancer: a single arm phase II trial

化疗联合瑞戈非尼和免疫检查点抑制剂作为晚期胆道癌患者的一线治疗方案:一项单臂 II 期试验

Liu, Jianwei; Bai, Shilei; Sun, Yanfu; Hu, Lei; Ge, Ruiliang; Xue, Feng

Surgical Strategies Affect the Long-Term Prognosis of Patients with Hepatocellular Carcinoma Adjacent to the Left Branch of the Portal Vein

手术策略影响门静脉左支邻近肝细胞癌患者的长期预后

Bai, Shilei; Shen, Xiaojing; Liu, Jianwei; Lu, Caixia; Wang, Jie; Liu, Liu; Wang, Chunyan; Wang, Huifeng; Liu, Kai; Sun, Yanfu; Xue, Feng

Comparison of the safety and prognosis of sequential regorafenib after sorafenib and lenvatinib treatment failure in patients with unresectable hepatocellular carcinoma: a retrospective cohort study

比较索拉非尼和乐伐替尼治疗失败后序贯使用瑞戈非尼治疗不可切除肝细胞癌患者的安全性和预后:一项回顾性队列研究

Zhai, Jian; Liu, Jianwei; Fu, Zhigang; Bai, Shilei; Li, Xiaowei; Qu, Zengqiang; Sun, Yanfu; Ge, Ruiliang; Xue, Feng

CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling.

环状RNA-9119通过阻断miR-26a/JAK1/STAT3信号通路来保护肝细胞癌细胞免于凋亡

Yang Lixue, Xue Hui, Sun Yanfu, Zhang Lei, Xue Feng, Ge Ruiliang

Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma

生物信息学分析鉴定出肝细胞癌的七种免疫相关风险特征

Xue, Feng; Yang, Lixue; Dai, Binghua; Xue, Hui; Zhang, Lei; Ge, Ruiliang; Sun, Yanfu

lncRNA AK054386 Functions as a ceRNA to Sequester miR-199 and Induce Sustained Endoplasmic Reticulum Stress in Hepatic Reperfusion Injury

lncRNA AK054386 作为 ceRNA 发挥作用,隔离 miR-199 并诱导肝脏再灌注损伤中持续的内质网应激

Dai, Binghua; Qiao, Liang; Zhang, Mingke; Cheng, Lipeng; Zhang, Ling; Geng, Li; Shi, Changying; Zhang, Minfeng; Sui, Chengjun; Shen, Weifeng; Sun, Yanfu; Chen, Qian; Hui, Dong; Wang, Yue; Yang, Jiamei